Variant report

Variant	nsv901474
Chromosome Location	chr14:21360233-21413602
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr14:21373948-21374221	HepG2	liver:	n/a	chr14:21374057-21374070
2	CEBPB	chr14:21387328-21387608	MCF-7	breast:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
3	CEBPB	chr14:21387233-21387541	K562	blood:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
4	CEBPB	chr14:21362153-21362361	IMR90	lung:	n/a	chr14:21362250-21362261
5	CEBPB	chr14:21390705-21391054	MCF-7	breast:	n/a	n/a
6	CEBPB	chr14:21404892-21405089	MCF-7	breast:	n/a	n/a
7	CEBPB	chr14:21390780-21390974	K562	blood:	n/a	n/a
8	CEBPB	chr14:21362247-21362271	H1-hESC	embryonic stem cell:	n/a	chr14:21362250-21362261
9	CEBPB	chr14:21387140-21387598	HepG2	liver:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
10	CEBPB	chr14:21387189-21387569	HepG2	liver:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
11	CEBPB	chr14:21362130-21362293	A549	lung:	n/a	chr14:21362250-21362261
12	CEBPB	chr14:21390675-21390974	A549	lung:	n/a	n/a
13	CEBPB	chr14:21387199-21387544	A549	lung:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
14	CEBPB	chr14:21387184-21387565	K562	blood:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
15	CEBPB	chr14:21387301-21387487	K562	blood:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
16	CEBPB	chr14:21404959-21405123	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr14:21387278-21387542	IMR90	lung:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
18	CEBPB	chr14:21387183-21387567	HepG2	liver:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
19	CEBPB	chr14:21362091-21362409	HepG2	liver:	n/a	chr14:21362250-21362261
20	CEBPB	chr14:21390712-21390883	Hela-S3	cervix:	n/a	n/a
21	CEBPB	chr14:21404946-21405126	K562	blood:	n/a	n/a
22	CEBPB	chr14:21387296-21387479	HepG2	liver:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
23	CEBPB	chr14:21362201-21362274	K562	blood:	n/a	chr14:21362250-21362261
24	CEBPB	chr14:21387197-21387553	H1-hESC	embryonic stem cell:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
25	CEBPB	chr14:21390806-21390847	H1-hESC	embryonic stem cell:	n/a	n/a
26	CEBPB	chr14:21387196-21387557	Hela-S3	cervix:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
27	CEBPB	chr14:21372661-21372946	H1-hESC	embryonic stem cell:	n/a	n/a
28	CEBPB	chr14:21362168-21362307	Hela-S3	cervix:	n/a	chr14:21362250-21362261
29	CEBPB	chr14:21390663-21390987	HepG2	liver:	n/a	n/a
30	CEBPD	chr14:21387228-21387447	HepG2	liver:	n/a	chr14:21387366-21387377 chr14:21387368-21387377
31	CTCF	chr14:21402420-21402570	AoAF	blood vessel:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
32	CTCF	chr14:21402400-21402550	HCPEpiC	choroid plexus:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
33	CTCF	chr14:21402380-21402530	HAc	cerebellar:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
34	CTCF	chr14:21402460-21402569	Lung_OC	lung:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
35	CTCF	chr14:21402420-21402570	GM12875	blood:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
36	CTCF	chr14:21372660-21372810	HepG2	liver:	n/a	n/a
37	CTCF	chr14:21363089-21363151	Fibrobl	skin:	n/a	n/a
38	CTCF	chr14:21372660-21372810	Caco-2	colon:	n/a	n/a
39	CTCF	chr14:21372573-21372869	K562	blood:	n/a	n/a
40	CTCF	chr14:21403520-21403670	HCT-116	colon:	n/a	n/a
41	CTCF	chr14:21402335-21402704	K562	blood:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
42	CTCF	chr14:21372600-21372750	HUVEC	blood vessel:	n/a	n/a
43	CTCF	chr14:21402400-21402550	GM12865	blood:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
44	CTCF	chr14:21402415-21402633	MCF-7	breast:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
45	CTCF	chr14:21402480-21402630	GM12801	blood:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
46	CTCF	chr14:21402400-21402550	GM12873	blood:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
47	CTCF	chr14:21402400-21402632	Fibrobl	skin:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
48	CTCF	chr14:21402460-21402610	HRE	kidney:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
49	CTCF	chr14:21372680-21372830	HCT-116	colon:	n/a	n/a
50	CTCF	chr14:21402480-21402630	Hela-S3	cervix:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr14:21386453-21386503	CMK	blood:	n/a
2	chr14:21386453-21386503	CMK	blood:	n/a
3	chr14:21386453-21386503	MCF-7	breast:	n/a
4	chr14:21386453-21386503	NB4	blood:	n/a
5	chr14:21386453-21386503	Jurkat	blood:	n/a
6	chr14:21386453-21386503	GM19239	blood:	n/a
7	chr14:21386453-21386503	T-47D	breast:	n/a
8	chr14:21386453-21386503	RPTEC	kidney:	n/a
9	chr14:21386453-21386503	HCT-116	colon:	n/a
10	chr14:21386453-21386503	IMR90	lung:	fetal
11	chr14:21386453-21386503	NH-A	brain:	n/a
12	chr14:21386453-21386503	ECC-1	luminal epithelium:	n/a
13	chr14:21386453-21386503	HepG2	liver:	n/a
14	chr14:21386453-21386503	BE2_C	brain:	n/a
15	chr14:21386453-21386503	PANC-1	pancreas:	n/a
16	chr14:21386453-21386503	Hepatocyte	liver:	n/a
17	chr14:21386453-21386503	NT2-D1	testis:	n/a
18	chr14:21386453-21386503	SAEC	small airway:	n/a
19	chr14:21386453-21386503	GM12892	blood:	n/a
20	chr14:21386453-21386503	PFSK-1	brain:	n/a
21	chr14:21386453-21386503	NHBE	bronchial:	n/a
22	chr14:21386453-21386503	Caco-2	colon:	n/a
23	chr14:21386453-21386503	ProgFib	skin:	n/a
24	chr14:21386453-21386503	AG09319	gingival:	n/a
25	chr14:21386453-21386503	H1-hESC	embryonic stem cell:	embryo
26	chr14:21386453-21386503	HL-60	blood:	n/a
27	chr14:21386453-21386503	HMEC	breast:	n/a
28	chr14:21386453-21386503	HPAEpiC	pulmonary alveolar:	n/a
29	chr14:21386453-21386503	HEK293	kidney:	embryo
30	chr14:21386453-21386503	AoSMC	blood vessel:	n/a
31	chr14:21386453-21386503	HEEpiC	esophagus:	n/a
32	chr14:21386453-21386503	GM12891	blood:	n/a
33	chr14:21386453-21386503	HRCEpiC	kidney:	n/a
34	chr14:21386453-21386503	NHDF-neo	bronchial:	n/a
35	chr14:21386453-21386503	HAEpiC	amniotic membrane:	n/a
36	chr14:21386453-21386503	GM12878	blood:	n/a
37	chr14:21386453-21386503	AG04449	skin:	fetal
38	chr14:21386453-21386503	SK-N-SH_RA	brain:	n/a
39	chr14:21386453-21386503	AG04450	lung:	fetal
40	chr14:21386453-21386503	HCM	heart:	n/a
41	chr14:21386453-21386503	HUVEC	blood vessel:	n/a
42	chr14:21386453-21386503	HRPEpiC	eye:	n/a
43	chr14:21386453-21386503	GM06990	blood:	n/a
44	chr14:21386453-21386503	HCPEpiC	choroid plexus:	n/a
45	chr14:21386453-21386503	U87	brain:	n/a
46	chr14:21386453-21386503	AG10803	skin:	n/a
47	chr14:21386453-21386503	A549	lung:	n/a
48	chr14:21386453-21386503	ovcar-3	ovarian:	n/a
49	chr14:21386453-21386503	BJ	skin:	n/a
50	chr14:21386453-21386503	AG09309	skin:	n/a

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RNASE3-1	chr14:21387795-21388335	ENSG00000136315
2	lnc-NDRG2-3	chr14:21366144-21366340	ENSG00000258918
3	lnc-RNASE3-1	chr14:21387500-21387563	ENSG00000136315
4	lnc-NDRG2-3	chr14:21404261-21404414	ENSG00000258918
5	lnc-NDRG2-2	chr14:21396396-21396739	ENSG00000258772
6	lnc-NDRG2-2	chr14:21384925-21385029	ENSG00000258772

Variant related genes	Relation type
ENSG00000258772	TF binding region
ENSG00000136315	TF binding region
ENSG00000258918	TF binding region
ENSG00000258772	CpG island
ENSG00000136315	CpG island
ENSG00000258918	CpG island

Extended variants
information (count: 1468 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:1468 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs12147890	chr14:21360233-21360234	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs555403976	chr14:21360240-21360241	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs572065181	chr14:21360260-21360261	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs141104135	chr14:21360262-21360263	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs375309421	chr14:21360291-21360292	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs150232577	chr14:21360305-21360306	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs369564860	chr14:21360311-21360312	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs533202480	chr14:21360336-21360337	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs2233860	chr14:21360344-21360345	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
10	rs371338819	chr14:21360349-21360350	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs182418195	chr14:21360357-21360358	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs140224611	chr14:21360365-21360366	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs377611699	chr14:21360377-21360378	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs549132652	chr14:21360405-21360406	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs8019343	chr14:21360422-21360423	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs528587048	chr14:21360444-21360445	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs551504194	chr14:21360456-21360457	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs373296643	chr14:21360494-21360495	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs370826207	chr14:21360512-21360513	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs369988476	chr14:21360534-21360535	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs537278077	chr14:21360560-21360561	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs76423109	chr14:21360596-21360597	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs143783614	chr14:21360599-21360600	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs2281643	chr14:21360623-21360624	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs535399652	chr14:21360655-21360656	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs73573913	chr14:21360657-21360658	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs572064220	chr14:21360670-21360671	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs187410936	chr14:21360687-21360688	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs116957985	chr14:21360688-21360689	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs577888509	chr14:21360747-21360748	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs543674499	chr14:21360755-21360756	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs190205877	chr14:21360800-21360801	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs573857829	chr14:21360833-21360834	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs542967319	chr14:21360845-21360846	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs537650947	chr14:21360861-21360862	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs146837487	chr14:21360876-21360877	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs181862417	chr14:21360905-21360906	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs185385317	chr14:21360969-21360970	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs529186446	chr14:21361109-21361110	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs539240728	chr14:21361119-21361120	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs11156743	chr14:21361129-21361130	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs567899759	chr14:21361189-21361190	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs190183876	chr14:21361209-21361210	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs140676460	chr14:21361269-21361270	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs139247263	chr14:21361285-21361286	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs565536357	chr14:21361313-21361314	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs75692555	chr14:21361317-21361318	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs539924235	chr14:21361333-21361334	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs534724215	chr14:21361369-21361370	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs75457062	chr14:21361370-21361371	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Cancer	20164920	CNVD
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cone-rod dystrophy	18421352	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16774939	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Alzheimer''s disease	21482944	CNVD
Mental retardation	19951919	CNVD
Neuroblastoma	21899760	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Heart disease	21282601	CNVD
Esophageal cancer	20955586	CNVD
Neurodevelopmental disorder	22521361	CNVD
Lung cancer	16773561	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17440070	CNVD
Breast cancer	16272173	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Epilepsy	20736978	CNVD
Mental retardation	20736978	CNVD
severe speech impairment	20736978	CNVD
speech impairment	20736978	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Prostate cancer	18632612	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Chronic myeloid leukemia	20724749	CNVD
Cancer	20164919	CNVD
Breast cancer	21364760	CNVD
Mortal	21835882	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:106 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:21356000-21362200	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr14:21359200-21360400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
3	chr14:21360200-21360800	Enhancers	Primary neutrophils fromperipheralblood	blood
4	chr14:21360400-21362400	Enhancers	Monocytes-CD14+_RO01746	blood
5	chr14:21360800-21361200	Weak transcription	Primary neutrophils fromperipheralblood	blood
6	chr14:21361200-21362200	Enhancers	Primary neutrophils fromperipheralblood	blood
7	chr14:21362200-21363200	Weak transcription	Primary monocytes fromperipheralblood	blood
8	chr14:21362200-21364600	Weak transcription	Primary neutrophils fromperipheralblood	blood
9	chr14:21362400-21363400	Weak transcription	Monocytes-CD14+_RO01746	blood
10	chr14:21363200-21363800	Enhancers	Primary monocytes fromperipheralblood	blood
11	chr14:21363400-21364200	Enhancers	Monocytes-CD14+_RO01746	blood
12	chr14:21363800-21364600	Weak transcription	Primary monocytes fromperipheralblood	blood
13	chr14:21364200-21364400	Weak transcription	Monocytes-CD14+_RO01746	blood
14	chr14:21364400-21364800	Enhancers	Monocytes-CD14+_RO01746	blood
15	chr14:21364600-21365600	Enhancers	Primary monocytes fromperipheralblood	blood
16	chr14:21364600-21365600	Enhancers	Primary neutrophils fromperipheralblood	blood
17	chr14:21364800-21365400	Weak transcription	Monocytes-CD14+_RO01746	blood
18	chr14:21365400-21365600	Enhancers	Monocytes-CD14+_RO01746	blood
19	chr14:21365600-21372400	Weak transcription	Monocytes-CD14+_RO01746	blood
20	chr14:21370400-21370600	Enhancers	Gastric	stomach
21	chr14:21371800-21373000	Enhancers	iPS-18 Cell Line	embryonic stem cell
22	chr14:21371800-21375600	Enhancers	Primary monocytes fromperipheralblood	blood
23	chr14:21372400-21372600	Enhancers	Monocytes-CD14+_RO01746	blood
24	chr14:21372400-21372800	Enhancers	iPS-20b Cell Line	embryonic stem cell
25	chr14:21372400-21373000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
26	chr14:21372400-21373000	Enhancers	HUES64 Cell Line	embryonic stem cell
27	chr14:21372400-21373200	Enhancers	ES-I3 Cell Line	embryonic stem cell
28	chr14:21372400-21373200	Enhancers	HUES48 Cell Line	embryonic stem cell
29	chr14:21372400-21373200	Enhancers	HUES6 Cell Line	embryonic stem cell
30	chr14:21372400-21373200	Enhancers	iPS-15b Cell Line	embryonic stem cell
31	chr14:21372600-21373000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr14:21372600-21373000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
33	chr14:21372600-21373000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
34	chr14:21372600-21374600	Enhancers	Primary hematopoietic stem cells short term culture	blood
35	chr14:21372600-21374800	Enhancers	Primary neutrophils fromperipheralblood	blood
36	chr14:21372800-21373200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
37	chr14:21373000-21373400	Enhancers	Monocytes-CD14+_RO01746	blood
38	chr14:21373400-21374000	Enhancers	Primary B cells from cord blood	blood
39	chr14:21373400-21374800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
40	chr14:21374800-21375400	Enhancers	Monocytes-CD14+_RO01746	blood
41	chr14:21378800-21379000	Flanking Active TSS	HepG2	liver
42	chr14:21379000-21379200	Active TSS	HepG2	liver
43	chr14:21385000-21386000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
44	chr14:21385000-21387400	Enhancers	Primary neutrophils fromperipheralblood	blood
45	chr14:21385000-21389400	Enhancers	Primary monocytes fromperipheralblood	blood
46	chr14:21385200-21387000	Enhancers	Monocytes-CD14+_RO01746	blood
47	chr14:21385400-21385800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
48	chr14:21386000-21386200	Enhancers	Primary hematopoietic stem cells short term culture	blood
49	chr14:21386000-21386400	Enhancers	Fetal Intestine Large	intestine
50	chr14:21386400-21387400	Weak transcription	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links